Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?

Reading time: 10 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?

Clinical Summary and Overview

In the realm of allergic and immune-mediated diseases, the topic Atopic Dermatitis It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. "Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?", offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Coronavírus — Tenho Dermatite Atópica, não tenho problemas respiratórios — Sou do grupo de risco?

Dermatite Atópica e o Coronavírus: A Criança com Afeção Cutânea é do Grupo de Risk?

Uma dúvida muito comum entre os pais durante o período crítico da pandemia de Covid-19 envolvia a segurança de crianças que apresentam condições alérgicas crônicas. Um exemplo típico é o caso de um pai que relatou que seu filho de dois anos possui dermatite atópica intensa, caracterizada por lesões avermelhadas e caroços pelo corpo, mas sem nenhum histórico de problemas respiratórios. A grande preocupação era saber se esse quadro cutâneo isolado classificava a criança como integrante do grupo de risco para complicações decorrentes da infecção pelo coronavírus.

Do ponto de vista médico e imunológico, o paciente que apresenta apenas a dermatite atópica restrita à pele, sem acometimento respiratório associado, não é considerado pertencente ao grupo de risco para formas graves da Covid-19. A dermatite atópica é uma doença inflamatória crônica da pele, caracterizada por disfunção na barreira cutânea e intensa coceira, mas a sua manifestação estritamente dermatológica não compromete a função pulmonar nem altera sistemicamente a resposta imunológica contra vírus respiratórios da mesma forma que as doenças pulmonares crônicas.

No entanto, o manejo diário desses pacientes exigia cuidados redobrados, especialmente devido às recomendações rigorosas de higienização das mãos e da pele durante a pandemia:

  • Impacto do álcool 70%: O uso frequente de álcool em gel ou líquido a 70% tende a ressecar drasticamente a pele, o que pode desencadear crises graves de dermatite atópica e fissuras cutâneas.
  • Escolha de formulações adequadas: Recomenda-se a busca por formulações de agentes antissépticos que possuam propriedades hidratantes e protetoras da barreira cutânea.
  • Atenção aos componentes: Os produtos utilizados para higienização e hidratação devem ser isentos de perfumes, fragrâncias e substâncias químicas agressivas que possam irritar ou piorar as lesões cutâneas da criança.

É fundamental destacar que o cenário clínico muda caso o paciente com dermatite atópica desenvolva comorbidades respiratórias associadas, como a asma alérgica ou a rinossinusite crônica, condições que fazem parte da chamada marcha atópica. Nesses casos em que há comprometimento das vias aéreas, a presença de hiper-reatividade brônquica pode representar um fator de risco adicional para complicações respiratórias em caso de infecção viral.

Cabe ressaltar que este conteúdo possui caráter exclusivamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e a orientação terapêutica individualizada com um médico especialista em Alergia e Imunologia.

Developments in Evidence-Based Medicine: Cutaneous Immunopathology and Restoration of the Epithelial Barrier

Evidence-based medicine demonstrates that chronic inflammatory dermatoses involve the interaction between epidermal barrier dysfunction (such as mutations or reduced expression of the protein). filaggrin and ceramides in the stratum corneum in atopic dermatitis, facilitating transepidermal water loss and the penetration of aeroallergens and staphylococcal antigens) and polarized immune activation (predominance of Th2/Th22 with IL-4, IL-13 and IL-31 in atopic dermatitis; delayed-type IV hypersensitivity mediated by T lymphocytes in allergic contact eczema diagnosed by contact test / patch test; and the IL-23/Th17/TNF-α axis in psoriasis). Structured management combines intensive restorative hydration, inflammation control with topical corticosteroids or calcineurin inhibitors (proactive therapy), eradication of proven triggers, and, in aeroallergen-sensitized or severe cases, specific immunotherapy and targeted therapies.

💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Skin Barrier Health, Immune Inflammation, and Pruritus Control

Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization

In eczematous dermatitis and cases of chronic pruritus, differentiating constitutional atopy from allergic contact dermatitis (a type IV delayed hypersensitivity reaction mediated by T lymphocytes sensitized to metals, cosmetic preservatives, fragrances, resins, or rubber) is essential. Repeated exposure to the sensitizing agent maintains active skin inflammation even with the use of anti-inflammatory ointments, requiring precise identification of the triggering factor.

Therapeutic Hydration, Skin Tests and Immunotherapy

Controlling the itch-scratch cycle requires ongoing management of subclinical inflammation through... vaccine for dermatitis, topical corticosteroid-sparing immunomodulators and administration of allergy test appropriate to the lesion profile. When household allergens play a significant role in worsening skin conditions, the indication for allergy vaccine It works by reducing immune hyper-reactivity and significantly spacing out relapses.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up through telemedicine and easy access to immunotherapy treatment. For peaceful skin, free from constant itching and sleep-depriving flare-ups.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

It is concluded that the efficient management of issues related to Atopic Dermatitis It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seeking evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established options for specialized allergy and immunology care whenever indicated—ensures clinical safety and lasting health protection.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: